Short description
OncoGenex develops and commercializes innovative therapies for the treatment of a variety of cancers.
Description
OncoGenex’ mission is to meet the challenge of treatment resistance through the development and commercialization of first-in-class, innovative therapies that have the potential to redefine treatment outcomes for patients with a variety of cancers.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Bothell, Washington, United States, North America
Founded on
January 1, 1991
Closed on
August 1, 2017
Exited on
October 20, 1995
Went public on
October 20, 1995
Delisted on
August 1, 2017
Stock symbol
OGXI
Non-profit?
No
Acquired?
No
Employees count
51-100
Investors
Noway Youcantaccess, No Way, Noaccess, Absolutely Noaccess, Noway Youcantaccess
Sign in for full access
Founders
Scott Cormack